$QWTR
Quest Water Global, Inc.

2023 Q3 Form 10-Q Financial Statement

#000149315223024965 Filed on July 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $140.4K $150.9K
YoY Change
% of Gross Profit
Research & Development $824.00 $816.00 $876.00
YoY Change 8.14% -6.85% 5.16%
% of Gross Profit
Depreciation & Amortization $130.00 $250.00
YoY Change
% of Gross Profit
Operating Expenses $140.5K $151.0K $142.7K
YoY Change -85.04% 5.82% 21.62%
Operating Profit -$142.7K
YoY Change 21.62%
Interest Expense -$2.330K -$6.530K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$140.5K -$151.0K -$142.7K
YoY Change -85.04% 5.82%
Income Tax
% Of Pretax Income
Net Earnings -$142.8K -$157.6K -$142.7K
YoY Change -84.79% 10.4% 21.62%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 131.9M shares 131.9M shares 85.16M shares
Diluted Shares Outstanding 131.9M shares 131.9M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.00
YoY Change
Cash & Equivalents $42.00 $110.00
Short-Term Investments
Other Short-Term Assets $4.860K $4.650K
YoY Change
Inventory
Prepaid Expenses $4.858K $4.647K $5.799K
Receivables
Other Receivables
Total Short-Term Assets $4.900K $4.647K $5.909K
YoY Change 8.72% -21.36%
LONG-TERM ASSETS
Property, Plant & Equipment $792.00 $917.00 $1.417K
YoY Change -38.7% -35.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $792.00 $917.00 $8.637K
YoY Change -90.7% -89.38%
TOTAL ASSETS
Total Short-Term Assets $4.900K $4.647K $5.909K
Total Long-Term Assets $792.00 $917.00 $8.637K
Total Assets $5.692K $5.564K $14.55K
YoY Change -56.28% -61.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $50.73K $48.39K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.724M $1.581M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.724M $1.581M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.724M $1.581M $3.972M
YoY Change 60.94% -60.21%
SHAREHOLDERS EQUITY
Retained Earnings -$11.72M -$11.58M -$10.29M
YoY Change 4.35% 12.49%
Common Stock $132.00 $132.00 $85.00
YoY Change 0.0% 55.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.718M -$1.575M -$3.958M
YoY Change
Total Liabilities & Shareholders Equity $5.692K $5.564K $14.55K
YoY Change -56.28% -61.75%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$142.8K -$157.6K -$142.7K
YoY Change -84.79% 10.4% 21.62%
Depreciation, Depletion And Amortization $130.00 $250.00
YoY Change
Cash From Operating Activities $40.00 $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 40.00 0.000
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities
Net Change In Cash 40.00 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities $40.00 $0.00
Capital Expenditures $0.00 $0.00
Free Cash Flow $40.00 $0.00
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001487091
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q2 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-168895
dei Entity Registrant Name
EntityRegistrantName
QUEST WATER GLOBAL, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1994359
dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 209 – 828 Harbourside Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
North Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V7P 3R9
dei City Area Code
CityAreaCode
(888)
dei Local Phone Number
LocalPhoneNumber
897-5536
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
131903029 shares
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4647 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1094 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
4647 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1094 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
917 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1167 usd
CY2023Q2 us-gaap Assets
Assets
5564 usd
CY2022Q4 us-gaap Assets
Assets
2261 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
48388 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37698 usd
CY2023Q2 QWTR Investment In Partnership Current
InvestmentInPartnershipCurrent
42732 usd
CY2022Q4 QWTR Investment In Partnership Current
InvestmentInPartnershipCurrent
33980 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1580628 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1275132 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
132 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
132 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10000348 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10000348 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11575545 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11273352 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1575064 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1272871 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5564 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2261 usd
CY2023Q2 QWTR Automotive Expenses
AutomotiveExpenses
2148 usd
CY2022Q2 QWTR Automotive Expenses
AutomotiveExpenses
2670 usd
QWTR Automotive Expenses
AutomotiveExpenses
4607 usd
QWTR Automotive Expenses
AutomotiveExpenses
5315 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
125 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
250 usd
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
123750 usd
CY2022Q2 us-gaap Management Fee Expense
ManagementFeeExpense
112500 usd
us-gaap Management Fee Expense
ManagementFeeExpense
247500 usd
us-gaap Management Fee Expense
ManagementFeeExpense
225000 usd
CY2023Q2 QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
1700 usd
CY2022Q2 QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
1563 usd
QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
3643 usd
QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
3253 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
10594 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
13375 usd
us-gaap Professional Fees
ProfessionalFees
13563 usd
us-gaap Depreciation
Depreciation
250 usd
us-gaap Depreciation
Depreciation
83 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3553 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5799 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10690 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4330 usd
us-gaap Professional Fees
ProfessionalFees
27156 usd
CY2023Q2 QWTR Rent
Rent
5485 usd
CY2022Q2 QWTR Rent
Rent
5539 usd
QWTR Rent
Rent
10970 usd
QWTR Rent
Rent
10789 usd
CY2023Q2 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
816 usd
CY2022Q2 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
876 usd
us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
1738 usd
us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
1839 usd
CY2023Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
6412 usd
CY2022Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
6198 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
11170 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
14004 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
151030 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
142721 usd
us-gaap Operating Expenses
OperatingExpenses
293441 usd
us-gaap Operating Expenses
OperatingExpenses
287356 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-151030 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142721 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-293441 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-287356 usd
CY2023Q2 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
6532 usd
QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
8752 usd
QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
7716 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-157562 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-142721 usd
us-gaap Net Income Loss
NetIncomeLoss
-302193 usd
us-gaap Net Income Loss
NetIncomeLoss
-295072 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131903029 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85164569 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131903029 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85164569 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1272871 usd
us-gaap Net Income Loss
NetIncomeLoss
-302193 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1575064 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3728198 usd
us-gaap Net Income Loss
NetIncomeLoss
-295072 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-4023270 usd
us-gaap Net Income Loss
NetIncomeLoss
-302193 usd
us-gaap Net Income Loss
NetIncomeLoss
-295072 usd
QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
8752 usd
QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
7716 usd
QWTR Increase Decrease In Due To Related Company
IncreaseDecreaseInDueToRelatedCompany
-7538 usd
QWTR Increase Decrease In Due To Related Company
IncreaseDecreaseInDueToRelatedCompany
-21358 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
293592 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
307483 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2617 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4117 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4227 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
110 usd
CY2023Q2 QWTR Working Capital Deficiency
WorkingCapitalDeficiency
1575981 usd
CY2023Q2 QWTR Liability To Principal Stockholders Due To Working Capital Deficiency
LiabilityToPrincipalStockholdersDueToWorkingCapitalDeficiency
1447205 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11575545 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
8752 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
7716 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85164569 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
302193 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
295072 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131903029 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85164569 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6300000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.10 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8500000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2200000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.10
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6300000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6300000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.10
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.10
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y14D
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment

Files In Submission

Name View Source Status
0001493152-23-024965-index-headers.html Edgar Link pending
0001493152-23-024965-index.html Edgar Link pending
0001493152-23-024965.txt Edgar Link pending
0001493152-23-024965-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
qwtr-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qwtr-20230630_cal.xml Edgar Link unprocessable
qwtr-20230630_def.xml Edgar Link unprocessable
qwtr-20230630_lab.xml Edgar Link unprocessable
qwtr-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending